JPH08332180A - System for continuous percutaneous measurement of blood sugar value - Google Patents

System for continuous percutaneous measurement of blood sugar value

Info

Publication number
JPH08332180A
JPH08332180A JP7142852A JP14285295A JPH08332180A JP H08332180 A JPH08332180 A JP H08332180A JP 7142852 A JP7142852 A JP 7142852A JP 14285295 A JP14285295 A JP 14285295A JP H08332180 A JPH08332180 A JP H08332180A
Authority
JP
Japan
Prior art keywords
suction
liquid
measurement
tissue fluid
valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7142852A
Other languages
Japanese (ja)
Other versions
JP2665485B2 (en
Inventor
Akio Kaneyoshi
昭雄 兼吉
Tokiji Nishida
時次 西田
Hironobu Iwasaki
博信 岩崎
Shiho Murakami
志緒 村上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technology Research Association of Medical and Welfare Apparatus
Original Assignee
Technology Research Association of Medical and Welfare Apparatus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Research Association of Medical and Welfare Apparatus filed Critical Technology Research Association of Medical and Welfare Apparatus
Priority to JP7142852A priority Critical patent/JP2665485B2/en
Publication of JPH08332180A publication Critical patent/JPH08332180A/en
Application granted granted Critical
Publication of JP2665485B2 publication Critical patent/JP2665485B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

PURPOSE: To make it possible to continuously measure a blood sugar value by integrating a series of operations including automatic collecting, weighing, measuring and washing of sucked tissue fluid having no need for blood taking. CONSTITUTION: A suction pump 5 is driven to suck a skin in the state of opening a flow passage opening and closing section 18, setting a weighing valve 13 at a direction A, setting a solenoid valve 8 for changing over flow passages at a direction A side and closing a solenoid valve 6 for opening to the atm. While the suction pressure is checked by a pressure sensor 4, the suction pump is stopped under about 1/2atm. Next, whether the measurement time is attained or not is judged. The liquid path opening and closing section 18 is closed and the solenoid valve 6 for opening to the atm. is opened for about one second to restore the atm. pressure in the suction path when the measurement time is attained. At this time, the weighing valve 13 is filled with the sucked tissue fluid. Next, the weighing valve 13 is rotated in a direction C and the sucked tissue fluid is delivered together with a diluting liquid to a sensor device 15 by a liquid feed pump 10 and thereafter, the fluid is diluted by rotating a stirring rod. The sensor signal is inputted to an A/D converter existing in a control section 1 and the sensor output is displayed on a display section 2. The sugar concn. is measured and displayed about two minutes after.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は血糖値の測定システムに
関し、特に吸引組織液を採取して、血糖値を連続的に測
定する経皮的連続血糖値測定システムに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a blood glucose level measuring system, and more particularly to a transcutaneous continuous blood glucose level measuring system for continuously measuring blood glucose level by collecting aspiration tissue fluid.

【0002】[0002]

【従来の技術】従来、血糖値の測定検査は、病院など
で、経静脈的に血液を採取し、これを遠心分離してその
中の血漿成分に含まれる糖濃度を専用の検査機器で、測
定したり、あるいは糖尿病患者においては医師の指導の
下で、穿刺によって得られた毛細管血を簡易型血糖計で
測定しこれを1日に数回行い血糖値の経時的変化を自己
管理しているというものであった。
2. Description of the Related Art Conventionally, a blood glucose level measurement test is performed at a hospital or the like by collecting blood intravenously, centrifuging the blood, and measuring the sugar concentration contained in plasma components in the blood with a special test device. Measure or, under the guidance of a physician, measure the capillary blood obtained by puncture with a simple blood glucose meter several times a day under the guidance of a physician. It was.

【0003】[0003]

【発明が解決しようとする課題】従来の血糖値測定方法
では採血が必要なため、患者に苦痛を与え、これを1日
数回行うとなると傷口からの感染の危険性にさらされる
という問題があった。また連続的に測定することが困難
であるため、血糖値の経時的変化を知るのは容易ではな
いという問題があった。
However, the conventional blood glucose measuring methods require blood sampling, which causes pain to the patient, and if this is done several times a day, there is a risk of infection from a wound. It was Further, since it is difficult to measure continuously, there is a problem that it is not easy to know a change in blood glucose level over time.

【0004】本発明の課題は、上記問題点を解消し、血
糖値を連続的に測定することを可能とする経皮的連続血
糖値測定システムを提供することである。
[0004] It is an object of the present invention to provide a transcutaneous continuous blood glucose level measuring system which solves the above-mentioned problems and enables continuous measurement of blood glucose level.

【0005】[0005]

【課題を解決するための手段】本発明によれば、減圧に
て皮膚より侵出した吸引組織液を集める吸引セルと、該
吸引セルにチューブを介して接続され、前記吸引組織液
を秤量し、吸引方向、液抜き方向、及び送液方向の3方
向に回転可能な秤量バルブと、皮膚の表面を減圧吸引す
る吸引ポンプ、前記吸引組織液に含まれる気泡を削減す
るための大気開放用電磁弁、前記吸引方向と前記液抜き
方向のいずれか一方に切り替えるための液路切替用電磁
弁からなる吸引系と、前記吸引組織液中の糖濃度を定量
するグルコースセンサを内蔵したセンサ装置、前記秤量
バルブ内の吸引組織液を希釈液とともに前記センサ装置
へ送出する送液ポンプ、及び測定終了後に行われる前記
希釈液による前記グルコースセンサの洗浄時に排出され
る排液を回収する排液部からなる送液系と、大気開放時
に皮膚面の減圧状態を維持するための液路開閉部と、糖
濃度の測定結果を表示する表示部、測定結果を記憶保存
する記憶部、並びに前記秤量バルブ、前記吸引系、前記
送液系、液路開閉部、前記表示部、及び前記記憶部の動
作制御を行う制御部からなる制御系を具備して構成され
ることを特徴とする経皮的連続血糖値測定システムが得
られる。
According to the present invention, a suction cell for collecting suction tissue fluid that has exuded from the skin under reduced pressure, and a tube connected to the suction cell, the suction tissue fluid is weighed and suctioned. Valve that can be rotated in three directions: the drainage direction, the liquid draining direction, and the liquid sending direction, a suction pump that vacuum-sucks the surface of the skin, a solenoid valve for opening to the atmosphere for reducing bubbles contained in the suctioned tissue fluid, A suction system consisting of a liquid path switching electromagnetic valve for switching to either one of the suction direction and the liquid draining direction, a sensor device having a glucose sensor for quantifying the sugar concentration in the suctioned tissue fluid, and the inside of the weighing valve. A liquid feed pump that sends the aspirated tissue fluid together with a diluent to the sensor device, and a drainage discharged when the glucose sensor is washed with the diluent after the measurement is completed. A liquid delivery system comprising a liquid part, a liquid path opening / closing part for maintaining a reduced pressure state of the skin surface when the air is opened to the air, a display part for displaying the measurement result of the sugar concentration, a storage part for storing and storing the measurement result, and A transdermal system comprising a control system including a weighing valve, the suction system, the liquid feeding system, a liquid path opening / closing section, the display section, and a control section for controlling the operation of the storage section. A continuous blood glucose measurement system is obtained.

【0006】さらに、本発明によれば、前記吸引系は、
前記秤量バルブに前記液路切替用電磁弁を介して接続さ
れ、前記吸引組織液及び前記希釈液が前記吸引ポンプに
侵入するのを防止するためのサンプルトラップを有して
いることを特徴とする経皮的連続血糖値測定システムが
得られる。
Further, according to the present invention, the suction system includes:
The weighing valve further includes a sample trap connected to the weighing valve via the liquid path switching electromagnetic valve to prevent the suctioned tissue fluid and the diluent from entering the suction pump. A continuous skin glucose measurement system is obtained.

【0007】さらに、本発明によれば、前記送液ポンプ
のモータの回転軸にはスリット付きの回転板が取り付け
られ、該スリットをフォトセンサで読み取ることにより
送液量を制御することを特徴とする経皮的連続血糖値測
定システムが得られる。
Further, according to the present invention, a rotary plate with a slit is attached to the rotary shaft of the motor of the liquid feed pump, and the liquid feed amount is controlled by reading the slit with a photo sensor. A transcutaneous continuous blood glucose level measuring system is obtained.

【0008】さらに、本発明によれば、測定前に、測定
間隔、測定時間等の測定条件を前記制御部に入力して前
記グルコースセンサの校正を行い、その校正は、濃度既
知のグルコース溶液を前記秤量バルブの液抜き方向の吸
引チューブが接続されていない側からシリンジで注入
し、これを前記センサ装置に送液してグルコースセンサ
と反応させ、前記吸引組織液を前記センサ装置へ送液後
に攪拌棒を回転させ、所定時間経過後の前記センサ装置
の出力電圧を記憶させて行われることを特徴とする経皮
的連続血糖値測定システムが得られる。
Further, according to the present invention, before the measurement, measurement conditions such as a measurement interval and a measurement time are input to the control unit, and the glucose sensor is calibrated. A syringe is injected from the side of the weighing valve in which the suction tube in the liquid removal direction is not connected, and is sent to the sensor device to react with the glucose sensor. After the suction tissue fluid is sent to the sensor device, stirring is performed. A transcutaneous continuous blood glucose measurement system is obtained by rotating the rod and storing the output voltage of the sensor device after a predetermined time has elapsed.

【0009】さらに、本発明によれば、前記排液部及び
前記サンプルトラップの中には高分子吸収材が設けられ
ていることを特徴とする経皮的連続血糖値測定システム
が得られる。
Further, according to the present invention, there is provided a percutaneous continuous blood glucose level measuring system characterized in that a polymer absorbent is provided in the drainage section and the sample trap.

【0010】[0010]

【実施例】次に本発明について図面を参照して説明す
る。図1は本発明の一実施例を示すブロック図である。
皮膚表面の角質層を除去した部分に吸引セル19を粘着
テープで固定する。吸引セルは円形で、皮膚との間に吸
引セルより小さい円形のナイロンメッシュ20を挿入す
る。ナイロンメッシュ20は吸引時に盛り上がる皮膚を
押え、吸引有効面積を維持し、皮膚への損傷を最小限に
押える役割をもつ。吸引セル19の中心には内径1mm
未満の吸引口を設け、1カ所に吸引組織液が集められ
る。吸引セル19はチューブを介して秤量バルブ13と
接続される。秤量バルブ13はモーター23により回転
可能で、吸引方向A、液抜き方向B、送液方向Cの各位
置で停止するように制御部1でコントロールする。
The present invention will be described below with reference to the drawings. FIG. 1 is a block diagram showing one embodiment of the present invention.
The suction cell 19 is fixed to the portion of the skin surface from which the stratum corneum has been removed with an adhesive tape. The suction cell is circular, and a circular nylon mesh 20 smaller than the suction cell is inserted between the suction cell and the skin. The nylon mesh 20 has a role of holding down the skin that rises during suction, maintaining the suction effective area, and minimizing damage to the skin. 1 mm inner diameter at the center of the suction cell 19
A suction port of less than is provided, and the suctioned tissue fluid is collected in one place. The suction cell 19 is connected to the weighing valve 13 via a tube. The weighing valve 13 is rotatable by a motor 23, and is controlled by the control unit 1 so as to stop at each position in the suction direction A, the liquid removal direction B, and the liquid feeding direction C.

【0011】吸引系は、吸引チューブ12を介して、液
路切替用電磁弁8、サンプルトラップ7、吸引ポンプ
5、圧力センサ4、大気開放用電磁弁6で構成されてい
る。液路切替用電磁弁8は、秤量バルブ13からサンプ
ルトラップ7への吸引路を、吸引方向Aか、液抜き方向
Bのいずれかに切り替えるためにある。サンプルトラッ
プ7は採取した吸引組織液や希釈液が吸引ポンプ5に侵
入するのを防止するためのものである。吸引中の圧力
は、圧力センサ4で制御部1により監視することが可能
である。大気開放用電磁弁6は、通常外部と吸引路を遮
断しているが、吸引組織液が秤量バルブ13に十分採取
された時には、外部と通じさせ、吸引路を大気と同じ圧
力にすることができる。液路開閉部18は通常開放状態
であるが、大気開放前に閉鎖し、大気開放しても皮膚面
は減圧が維持されるようになっている。これは、皮膚面
を大気開放すると、吸引により隆起していた皮膚が下が
り、そのため秤量バルブ13に採取された吸引組織液が
無くなってしまうのを防止するためである。液路開閉部
18はモーターと偏心カムの組合せにより、回転を水平
方向の動きに変換しており、停止は、モーターの回転板
に取り付けたスリットをフォトセンサで読み取ることで
制御している。
The suction system includes a liquid passage switching electromagnetic valve 8, a sample trap 7, a suction pump 5, a pressure sensor 4, and an atmosphere opening electromagnetic valve 6 via a suction tube 12. The liquid path switching electromagnetic valve 8 is for switching the suction path from the weighing valve 13 to the sample trap 7 in either the suction direction A or the liquid removal direction B. The sample trap 7 is for preventing the collected suctioned tissue fluid or diluent from entering the suction pump 5. The pressure during suction can be monitored by the control unit 1 using the pressure sensor 4. Although the air release electromagnetic valve 6 normally shuts off the suction passage from the outside, when the suctioned tissue fluid is sufficiently collected by the weighing valve 13, the suction passage can be communicated with the outside and the suction passage can be set to the same pressure as the atmosphere. . Although the fluid channel opening / closing section 18 is normally open, it is closed before being opened to the atmosphere, so that the skin surface is maintained under reduced pressure even when opened to the atmosphere. This is to prevent the raised skin from lowering due to suction when the skin surface is opened to the atmosphere, thereby preventing the suctioned tissue fluid collected by the weighing valve 13 from being lost. The liquid path opening / closing section 18 converts rotation into horizontal movement by a combination of a motor and an eccentric cam, and the stop is controlled by reading a slit attached to a rotating plate of the motor with a photo sensor.

【0012】送液系は、希釈液パック9、送液ポンプ1
0、センサ装置15、及び排液部14から構成される。
送液ポンプ10はしごき式で、希釈液パック9から希釈
液をセンサ装置15へ送液するためのものである。送液
ポンプ10のモーターの回転軸にはスリット付の回転板
を設置し、スリットをフォトセンサで読み取ることによ
り送液量を制御している。センサ装置15には、糖濃度
を測定するグルコースセンサ16を内蔵している。
The liquid feed system includes a diluent pack 9 and a liquid feed pump 1
0, the sensor device 15, and the drainage unit 14.
The liquid sending pump 10 is of an ironing type, and is for sending the diluting liquid from the diluting liquid pack 9 to the sensor device 15. A rotary plate with a slit is installed on the rotary shaft of the motor of the liquid feed pump 10, and the liquid feed amount is controlled by reading the slit with a photo sensor. The sensor device 15 has a built-in glucose sensor 16 for measuring the sugar concentration.

【0013】グルコースセンサ16は、イオン感応性電
界効果トランジスタ(Ion Sensitive F
ield Effect Transistor)を応
用したもので、測定後洗浄することによって繰り返し使
用することが可能である。秤量バルブ13で採取された
吸引組織液は送液ポンプ10によって希釈液とともにセ
ンサ装置15に送出され、グルコースセンサ16と接触
する構造になっている。測定中は撹拌棒17を撹拌モー
ター21にて回転することによって、試料を希釈し、規
程の希釈倍率にしている。測定後は、希釈液でグルコー
スセンサ16を洗浄し、排液部14で回収している。排
液部14とサンプルトラップ7の中には、市販の紙おむ
つに使用されている高分子吸収材を設置しており、汚染
された液を、これに吸収させて廃棄しやすい形態とし
た。
The glucose sensor 16 includes an ion-sensitive field effect transistor (Ion Sensitive F).
It is an application of the Field Effect Transistor, and can be repeatedly used by washing after measurement. The suctioned tissue fluid collected by the weighing valve 13 is sent to the sensor device 15 together with the diluting solution by the solution sending pump 10, and is brought into contact with the glucose sensor 16. During the measurement, the sample is diluted by rotating the stirring rod 17 by the stirring motor 21 to obtain a specified dilution ratio. After the measurement, the glucose sensor 16 is washed with the diluent and collected in the drainage unit 14. A polymer absorbent used for a commercially available disposable diaper is provided in the drainage section 14 and the sample trap 7, and the contaminated liquid is absorbed by the polymer absorbent so that the liquid can be easily disposed.

【0014】制御系は、制御部1、表示部2、透明タッ
チパネル22、メモリカード3で構成されている。制御
部1はマイクロプロセッサと各種のインターフェースか
ら成り、装置全体の制御を行っている。表示部2は液晶
表示器であり、この画面上に透明タッチパネル22を設
置し、表示された文字の部分を指で押すことによって、
この装置の操作が行える。吸引中、測定中、結果表示、
洗浄中などの文字が表示部2に表示され、操作者に状態
を知らせることができる。メモリカード3は電池内蔵の
ICメモリカードで、測定終了後は、取り外してパソコ
ンでデータを読み取ることが可能である。
The control system includes a control unit 1, a display unit 2, a transparent touch panel 22, and a memory card 3. The control unit 1 includes a microprocessor and various interfaces, and controls the entire apparatus. The display unit 2 is a liquid crystal display, and a transparent touch panel 22 is installed on this screen, and by pressing the displayed character portion with a finger,
This device can be operated. During aspiration, during measurement, result display,
Characters such as “washing” are displayed on the display unit 2 to inform the operator of the state. The memory card 3 is an IC memory card with a built-in battery, and after the measurement is completed, it can be removed and the data can be read by a personal computer.

【0015】図2は連続測定時のフローチャートであ
る。連続測定を行う前に被検者の年齢、体重などのID
情報や、測定間隔、測定時間などの測定条件を透明タッ
チパネル22から入力し(ステップS101)、グルコ
ースセンサ16の出力校正を行う(ステップS10
2)。校正は、濃度既知のグルコース溶液を秤量バルブ
13の液抜き方向の、吸引チューブ12が接続されてい
ない側から、シリンジで注入し、これをセンサ装置15
に送液して、グルコースセンサと反応させる。
FIG. 2 is a flowchart at the time of continuous measurement. Before performing continuous measurement, ID of subject's age, weight, etc.
Information and measurement conditions such as measurement intervals and measurement times are input from the transparent touch panel 22 (step S101), and the output of the glucose sensor 16 is calibrated (step S10).
2). For calibration, a glucose solution having a known concentration is injected with a syringe from the side of the weighing valve 13 in the liquid removal direction to which the suction tube 12 is not connected, and this is injected into the sensor device 15.
To react with the glucose sensor.

【0016】試料をセンサ装置15へ送液後、撹拌棒を
回転させながら、約2分後のセンサ出力電圧を記憶して
おく。校正液でのセンサ出力電圧をVC 、校正液濃度を
C、吸引組織液でのセンサ出力電圧をVS とすると、
吸引組織液中の糖濃度CS は以下に示す数1で換算され
る。
After feeding the sample to the sensor device 15, the sensor output voltage after about 2 minutes is stored while rotating the stirring rod. Assuming that the sensor output voltage of the calibration fluid is V C , the concentration of the calibration fluid is C C , and the sensor output voltage of the aspiration tissue fluid is V S ,
The sugar concentration C S in the suctioned tissue fluid is converted by the following equation (1).

【0017】[0017]

【数1】 校正終了後、測定条件入力で指示された測定間隔で自動
的に測定を繰り返す。初めに液路開閉部は開放、秤量バ
ルブ13はA方向、液路切替用電磁弁8はA方向側、大
気開放電磁弁6は閉鎖した状態で吸引ポンプ5を駆動さ
せ、皮膚を吸引する(ステップS103)。吸引圧は圧
力センサ4でチェックしながら、約1/2気圧で吸引ポ
ンプを停止する。次に測定時刻になったか否かを判断し
(ステップS104)、測定時刻になったら(ステップ
S104でYes)液路開閉部18を閉鎖し、大気開放
電磁弁6を約1秒開放し、吸引路を大気圧に戻す(ステ
ップS105)。この時、低圧下で発生した吸引組織液
中の気泡が縮小したり、秤量バルブ13の下部にある気
泡が浮上し、秤量バルブ13の中には、吸引組織液が満
たされる。次に秤量バルブ13をC方向へ回転させ、送
液ポンプ10で希釈液といっしょに吸引組織液をセンサ
装置15へ送出する(ステップS106)。送液が終る
と撹拌棒を回転し希釈する。センサ信号は制御部1内に
あるA/Dコンバータに入力され、センサ出力を表示部
2に表示する。約2分後、上記数1に従って糖濃度を測
定し、表示する(ステップS107)。
[Equation 1] After the calibration is completed, the measurement is automatically repeated at the measurement interval specified by the measurement condition input. First, the liquid passage opening / closing portion is opened, the weighing valve 13 is in the A direction, the liquid passage switching electromagnetic valve 8 is in the A direction side, and the atmosphere opening electromagnetic valve 6 is closed, and the suction pump 5 is driven to suck the skin ( Step S103). While checking the suction pressure with the pressure sensor 4, the suction pump is stopped at about 1/2 atm. Next, it is determined whether or not it is the measurement time (step S104), and when the measurement time is reached (Yes in step S104), the liquid passage opening / closing portion 18 is closed, the atmosphere opening solenoid valve 6 is opened for about 1 second, and suction is performed. The road is returned to atmospheric pressure (step S105). At this time, the bubbles in the aspiration tissue fluid generated under low pressure are reduced or the bubbles in the lower part of the weighing valve 13 are floated up, and the aspiration tissue fluid is filled in the weighing valve 13. Next, the weighing valve 13 is rotated in the C direction, and the sucking tissue fluid together with the diluting solution is sent to the sensor device 15 by the solution sending pump 10 (step S106). When the liquid transfer is complete, rotate the stir bar to dilute. The sensor signal is input to the A / D converter in the control unit 1, and the sensor output is displayed on the display unit 2. After about 2 minutes, the sugar concentration is measured according to the above equation 1 and displayed (step S107).

【0018】測定終了後、送液ポンプ10で希釈液を送
液し、センサを洗浄する(ステップS108)。この時
も、センサ出力をモニターし、センサ出力電圧が糖との
反応前のレベルに戻れば洗浄を中止する。次に秤量バル
ブ13をB方向にし、大気開放電磁弁6を閉鎖し、液路
切替用電磁弁8をB側にして一定時間吸引すると、洗浄
時に秤量バルブ13を満たした希釈液は除去され、サン
プルトラップ7へ送られる。これにより、次の吸引採取
時には吸引組織液と希釈液が混ざることなく、コンタミ
ネーションの防止が行える。次にこの測定が最終回の測
定か否か判断し(ステップS110)、最終回でなけれ
ば(ステップS110でNo)次の吸引を行う。
After the measurement is completed, the diluting solution is sent by the solution sending pump 10 to wash the sensor (step S108). Also at this time, the sensor output is monitored, and if the sensor output voltage returns to the level before the reaction with sugar, the washing is stopped. Next, the weighing valve 13 is set in the B direction, the air opening electromagnetic valve 6 is closed, and the liquid path switching electromagnetic valve 8 is set to the B side and suction is performed for a certain period of time. It is sent to the sample trap 7. As a result, the contamination can be prevented without mixing the aspiration tissue fluid and the diluent at the time of the next aspiration collection. Next, it is determined whether or not this measurement is the final measurement (step S110), and if it is not the final measurement (No in step S110), the next suction is performed.

【0019】秤量バルブ13を再びA方向にして、液路
切替用電磁弁8をA側にして再吸引し、1/2気圧にな
った時点で吸引ポンプを停止し、液路開閉部18を開放
し、次の測定時刻まで吸引組織液の採取を待つ。以上の
繰り返しにより、自動的に、かつ、連続的に吸引組織液
を採取し糖濃度を測定することが可能となる。
The weighing valve 13 is again set in the A direction, the liquid path switching solenoid valve 8 is set to the A side, and suction is performed again. When the pressure reaches 1/2 atm, the suction pump is stopped, and the liquid path opening / closing section 18 is closed. Open and wait for the collection of aspirated tissue fluid until the next measurement time. By repeating the above, it is possible to automatically and continuously collect the suctioned tissue fluid and measure the sugar concentration.

【0020】図3は本発明の一実施例を示す外観図であ
る。本装置は本体24と吸引装着部25に分かれる。本
体は本体ベルト27で腰に装着可能で、吸引装着部25
はベルト28により腕などに固定されるようになってい
る。
FIG. 3 is an external view showing an embodiment of the present invention. The device is divided into a main body 24 and a suction mounting portion 25. The main body can be mounted on the waist by the main body belt 27, and the suction mounting portion 25
Is fixed to an arm or the like by a belt 28.

【0021】本体24と吸引装着部25はケーブル26
で接続されている。ケーブル26は吸引路、送液路とな
るチューブと電線を一体化したもので、コネクタ31で
接続する。キーは電源スイッチ29のみで、操作は表示
部2上の透明タッチパネル22で行う。ふた30を開け
ると、希釈液パック9の交換、排液部14及びサンプル
トラップ7内の高分子吸収材の交換、ICメモリカード
の脱着、バッテリの交換が行える構造になっている。
The main body 24 and the suction mounting section 25 are connected to a cable 26.
Connected by. The cable 26 is formed by integrating a tube and a wire, which are a suction path and a liquid supply path, and is connected by a connector 31. The key is only the power switch 29, and the operation is performed on the transparent touch panel 22 on the display unit 2. When the lid 30 is opened, the diluent pack 9 can be replaced, the polymer absorbent in the drain unit 14 and the sample trap 7 can be replaced, the IC memory card can be removed, and the battery can be replaced.

【0022】[0022]

【発明の効果】以上説明したように、本発明によれば、
採血の必要がない吸引組織液を自動的に採取、秤量、測
定、洗浄する一連の動作を一体化させたので、血糖値を
連続的に測定することが可能となる。
As described above, according to the present invention,
Since a series of operations for automatically collecting, weighing, measuring, and washing the aspirated tissue fluid that does not require blood collection is integrated, it is possible to continuously measure the blood glucose level.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明に係る経皮的連続血糖値測定システムの
一実施例を示したブロック図である。
FIG. 1 is a block diagram showing an embodiment of a transcutaneous continuous blood glucose measurement system according to the present invention.

【図2】本発明に係る経皮的連続血糖値測定システムに
おける連続測定の工程を示したフローチャートである。
FIG. 2 is a flowchart showing steps of continuous measurement in the continuous transcutaneous blood glucose level measurement system according to the present invention.

【図3】本発明に係る経皮的連続血糖値測定システムを
示した概観斜視図である。
FIG. 3 is a schematic perspective view showing a transcutaneous continuous blood glucose level measuring system according to the present invention.

【符号の説明】[Explanation of symbols]

1 制御部 2 表示部 3 メモリカード 4 圧力センサ 5 吸引ポンプ 6 大気開放用電磁弁 7 サンプルトラップ 8 液路切替用電磁弁 9 希釈液パック 10 送液ポンプ 11 送液チューブ 12 吸引チューブ 13 秤量バルブ 14 排液部 15 センサ装置 16 グルコースセンサ 17 撹拌棒 18 液路開閉部 19 吸引セル 20 ナイロンメッシュ 21 撹拌モーター 22 透明タッチパネル 23 モーター 24 本体 25 吸引装着部 26 ケーブル 27 本体ベルト 28 吸引装着部ベルト 29 電源スイッチ 30 ふた 31 コネクタ 1 Control Section 2 Display Section 3 Memory Card 4 Pressure Sensor 5 Suction Pump 6 Solenoid Valve for Atmosphere Opening 7 Sample Trap 8 Solenoid Valve for Switching Liquid Path 9 Diluting Liquid Pack 10 Liquid Transfer Pump 11 Liquid Supply Tube 12 Suction Tube 13 Weighing Valve 14 Drainage part 15 Sensor device 16 Glucose sensor 17 Stirring bar 18 Liquid passage opening / closing part 19 Suction cell 20 Nylon mesh 21 Stirring motor 22 Transparent touch panel 23 Motor 24 Main body 25 Suction mounting part 26 Cable 27 Main body belt 28 Suction mounting part belt 29 Power switch 30 Lid 31 Connector

───────────────────────────────────────────────────── フロントページの続き (72)発明者 村上 志緒 東京都港区芝五丁目7番1号 日本電気株 式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Shio Murakami 5-7-1, Shiba, Minato-ku, Tokyo NEC Corporation

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 減圧にて皮膚より侵出した吸引組織液を
集める吸引セルと、該吸引セルにチューブを介して接続
され、前記吸引組織液を秤量し、吸引方向、液抜き方
向、及び送液方向の3方向に回転可能な秤量バルブと、
皮膚の表面を減圧吸引する吸引ポンプ、前記吸引組織液
に含まれる気泡を削減するための大気開放用電磁弁、前
記吸引方向と前記液抜き方向のいずれか一方に切り替え
るための液路切替用電磁弁からなる吸引系と、前記吸引
組織液中の糖濃度を定量するグルコースセンサを内蔵し
たセンサ装置、前記秤量バルブ内の吸引組織液を希釈液
とともに前記センサ装置へ送出する送液ポンプ、及び測
定終了後に行われる前記希釈液による前記グルコースセ
ンサの洗浄時に排出される排液を回収する排液部からな
る送液系と、大気開放時に皮膚面の減圧状態を維持する
ための液路開閉部と、糖濃度の測定結果を表示する表示
部、測定結果を記憶保存する記憶部、並びに前記秤量バ
ルブ、前記吸引系、前記送液系、液路開閉部、前記表示
部、及び前記記憶部の動作制御を行う制御部からなる制
御系を具備して構成されることを特徴とする経皮的連続
血糖値測定システム。
1. A suction cell for collecting suctioned tissue fluid that has exuded from the skin under reduced pressure, and a suction cell connected to the suction cell via a tube, and the suctioned tissue fluid is weighed, and the suction direction, the draining direction, and the liquid feeding direction. And a weighing valve that can rotate in three directions,
A suction pump for decompressing the surface of the skin, a solenoid valve for opening to the atmosphere to reduce air bubbles contained in the suctioned tissue fluid, and a solenoid valve for switching a fluid path for switching to one of the suction direction and the drainage direction. And a sensor device having a glucose sensor for quantifying the sugar concentration in the aspirated tissue fluid, a pump for delivering the aspirated tissue fluid in the weighing valve together with a diluent to the sensor device, and a method after the measurement is completed. A liquid delivery system consisting of a drainage part for collecting drainage discharged when the glucose sensor is washed with the diluted liquid, a liquid passage opening / closing part for maintaining a depressurized state of the skin surface when exposed to the atmosphere, and a sugar concentration A display unit for displaying the measurement result, a storage unit for storing and storing the measurement result, and the weighing valve, the suction system, the liquid delivery system, the liquid passage opening / closing unit, the display unit, and the storage unit. Percutaneous continuous blood sugar measuring system characterized by being configured by including a control system comprising a control unit that performs operation control.
【請求項2】 前記吸引系は、前記秤量バルブに前記液
路切替用電磁弁を介して接続され、前記吸引組織液及び
前記希釈液が前記吸引ポンプに侵入するのを防止するた
めのサンプルトラップを有していることを特徴とする請
求項1記載の経皮的連続血糖値測定システム。
2. The suction system is connected to the weighing valve via the liquid path switching electromagnetic valve, and includes a sample trap for preventing the suctioned tissue fluid and the diluent from entering the suction pump. The percutaneous continuous blood glucose level measuring system according to claim 1, which has.
【請求項3】 前記送液ポンプのモータの回転軸にはス
リット付きの回転板が取り付けられ、該スリットをフォ
トセンサで読み取ることにより送液量を制御することを
特徴とする請求項1記載の経皮的連続血糖値測定システ
ム。
3. The liquid supply pump according to claim 1, wherein a rotation plate having a slit is attached to a rotation shaft of the motor of the liquid supply pump, and the amount of liquid supply is controlled by reading the slit with a photosensor. A transcutaneous continuous blood glucose measurement system.
【請求項4】 測定前に、測定間隔、測定時間等の測定
条件を前記制御部に入力して前記グルコースセンサの校
正を行い、その校正は、濃度既知のグルコース溶液を前
記秤量バルブの液抜き方向の吸引チューブが接続されて
いない側からシリンジで注入し、これを前記センサ装置
に送液してグルコースセンサと反応させ、前記吸引組織
液を前記センサ装置へ送液後に攪拌棒を回転させ、所定
時間経過後の前記センサ装置の出力電圧を記憶させて行
われることを特徴とする請求項1記載の経皮的連続血糖
値測定システム。
4. Before measurement, the glucose sensor is calibrated by inputting measurement conditions such as measurement interval and measurement time to the control unit, and the calibration is performed by removing a glucose solution of known concentration from the weighing valve. Inject with a syringe from the side where the suction tube is not connected, feed this to the sensor device to react with the glucose sensor, rotate the stirring rod after feeding the suctioned tissue fluid to the sensor device, 2. The transcutaneous continuous blood glucose level measuring system according to claim 1, wherein the output voltage of the sensor device after a lapse of time is stored.
【請求項5】 前記排液部及び前記サンプルトラップの
中には高分子吸収材が設けられていることを特徴とする
請求項1記載の経皮的連続血糖値測定システム。
5. The continuous transcutaneous blood glucose measurement system according to claim 1, wherein a polymer absorbent is provided in the drainage section and the sample trap.
JP7142852A 1995-06-09 1995-06-09 Percutaneous continuous blood glucose measurement system Expired - Fee Related JP2665485B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7142852A JP2665485B2 (en) 1995-06-09 1995-06-09 Percutaneous continuous blood glucose measurement system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7142852A JP2665485B2 (en) 1995-06-09 1995-06-09 Percutaneous continuous blood glucose measurement system

Publications (2)

Publication Number Publication Date
JPH08332180A true JPH08332180A (en) 1996-12-17
JP2665485B2 JP2665485B2 (en) 1997-10-22

Family

ID=15325125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7142852A Expired - Fee Related JP2665485B2 (en) 1995-06-09 1995-06-09 Percutaneous continuous blood glucose measurement system

Country Status (1)

Country Link
JP (1) JP2665485B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004510453A (en) * 1998-07-21 2004-04-08 スペクトルクス,インコーポレイティド Systems and methods for continuous analyte monitoring
JP2007296327A (en) * 2006-04-05 2007-11-15 Nikkiso Co Ltd Biocomponent measurement unit, biocomponent measurement unit package, medical support instrument kit, and medical support instrument kit package
WO2008093494A1 (en) * 2007-01-30 2008-08-07 Nikkiso Co., Ltd. Monitor and living body measuring device
JP2008224695A (en) * 2008-06-23 2008-09-25 Sysmex Corp Analyzer for animals
US8668869B2 (en) 2003-07-16 2014-03-11 Sysmex Corporation Analyzer
KR101636781B1 (en) * 2015-02-09 2016-07-07 주식회사 에이엠피올 Intercellular fluid extraction structure for detecting glucose
KR101637325B1 (en) * 2015-02-09 2016-07-08 주식회사 에이엠피올 Degradation prevention structure for vital reaction of in vivo implantable continuous glucose monitoring sensor
WO2017065565A1 (en) * 2015-10-14 2017-04-20 주식회사 아이센스 Blood sugar measurement and sensing module having automatic calibration function and apparatus for continuous blood sugar measurement using same
CN114397141A (en) * 2021-12-10 2022-04-26 连云港市东方医院 Department of neurology is clinical with getting liquid device

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012020158A (en) * 1998-07-21 2012-02-02 Guided Therapeutics Inc System and method for continuous analyte monitoring
JP2004510453A (en) * 1998-07-21 2004-04-08 スペクトルクス,インコーポレイティド Systems and methods for continuous analyte monitoring
JP2013009992A (en) * 1998-07-21 2013-01-17 Guided Therapeutics Inc System and method for continuous analyte monitoring
JP2010194343A (en) * 1998-07-21 2010-09-09 Guided Therapeutics Inc System and method for continuous analyte monitoring
US8668869B2 (en) 2003-07-16 2014-03-11 Sysmex Corporation Analyzer
JP2007296327A (en) * 2006-04-05 2007-11-15 Nikkiso Co Ltd Biocomponent measurement unit, biocomponent measurement unit package, medical support instrument kit, and medical support instrument kit package
JP2008183250A (en) * 2007-01-30 2008-08-14 Nikkiso Co Ltd Monitor and artificial pancreas apparatus
US8340739B2 (en) 2007-01-30 2012-12-25 Nikkiso Co., Ltd. Monitor device and biological component-measuring device
WO2008093494A1 (en) * 2007-01-30 2008-08-07 Nikkiso Co., Ltd. Monitor and living body measuring device
JP4615589B2 (en) * 2008-06-23 2011-01-19 シスメックス株式会社 Veterinary blood cell counter
JP2008224695A (en) * 2008-06-23 2008-09-25 Sysmex Corp Analyzer for animals
KR101636781B1 (en) * 2015-02-09 2016-07-07 주식회사 에이엠피올 Intercellular fluid extraction structure for detecting glucose
KR101637325B1 (en) * 2015-02-09 2016-07-08 주식회사 에이엠피올 Degradation prevention structure for vital reaction of in vivo implantable continuous glucose monitoring sensor
WO2017065565A1 (en) * 2015-10-14 2017-04-20 주식회사 아이센스 Blood sugar measurement and sensing module having automatic calibration function and apparatus for continuous blood sugar measurement using same
CN114397141A (en) * 2021-12-10 2022-04-26 连云港市东方医院 Department of neurology is clinical with getting liquid device

Also Published As

Publication number Publication date
JP2665485B2 (en) 1997-10-22

Similar Documents

Publication Publication Date Title
EP1450686B1 (en) Device for sampling blood droplets under vacuum conditions
JP3765794B2 (en) System for monitoring the concentration of analyte in body fluids
US5050604A (en) Apparatus and method for monitoring the health condition of a subject
JP4212666B2 (en) Body fluid analyzer
JP2665485B2 (en) Percutaneous continuous blood glucose measurement system
US20040248312A1 (en) Sensor with integrated lancet
JP2684871B2 (en) Body fluid component measuring method and measuring device
EP1839577A1 (en) Sensor with integrated lancet
WO2000013580A9 (en) Device for determination of an analyte in a body fluid intergrated with an insulin pump
JP2630005B2 (en) Liquid component measuring device and measuring method
JP2000232971A (en) Sucked transudate sampling method and device
JP2003083958A (en) Blood analyzer and blood analyzing method
JP2751978B2 (en) Non-invasive continuous blood glucose meter
JP2958367B2 (en) Tissue fluid suction sampling device
CN205015278U (en) Blood -sugar content analytical equipment
JP3694563B2 (en) Body fluid analyzer
JPS61203947A (en) On-line monitoring apparatus for living body
JP2687947B2 (en) Leachate suction device
JP2955623B2 (en) Blood glucose measurement device
JPH10246727A (en) Sample dispenser for blood analyzer
JP2955624B2 (en) Blood glucose measurement device
CN220418891U (en) Sample collection and detection integrated device
JP2569879B2 (en) Suction leachate collection device, suction leachate amount measurement device, and biological related substance measurement device
JPH04193164A (en) Blood glucose measuring device
JPH04150836A (en) Blood sugar measuring apparatus

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19970311

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees